NIH COVID-19 Treatment Guidelines:
- “There is insufficient evidence for the Panel to recommend either for OR AGAINST the use of ivermectin for the treatment of COVID-19.” (Pg 100)
- Remdesivir Adverse Events: “Drug vehicle is SBECD, which has been associated with renal and liver toxicity. SBECD accumulation may occur in patients with moderate or severe renal impairment.” (Pg 159)
- Ivermectin Adverse Events: “Generally well tolerated” (Pg 161)
https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
https://www.covid19treatmentguidelines.nih.gov
@ChiefNerd
- “There is insufficient evidence for the Panel to recommend either for OR AGAINST the use of ivermectin for the treatment of COVID-19.” (Pg 100)
- Remdesivir Adverse Events: “Drug vehicle is SBECD, which has been associated with renal and liver toxicity. SBECD accumulation may occur in patients with moderate or severe renal impairment.” (Pg 159)
- Ivermectin Adverse Events: “Generally well tolerated” (Pg 161)
https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
https://www.covid19treatmentguidelines.nih.gov
@ChiefNerd
Forwarded from Disclose.tv
The Gates Foundation has granted over $500,000 to efforts related to smallpox, with the most recent grant in Sept 2021 going to:
“Increase public awareness and understanding of modern science, medicine, public health issues and the incredible effort that led to the eradication of smallpox”
A Nov 2019 grant went “to investigate the origin and evolution of the smallpox vaccine”
https://www.gatesfoundation.org/about/committed-grants?q=Smallpox
@ChiefNerd
“Increase public awareness and understanding of modern science, medicine, public health issues and the incredible effort that led to the eradication of smallpox”
A Nov 2019 grant went “to investigate the origin and evolution of the smallpox vaccine”
https://www.gatesfoundation.org/about/committed-grants?q=Smallpox
@ChiefNerd
This media is not supported in your browser
VIEW IN TELEGRAM
A message from a former Army psyops officer
https://www.tiktok.com/@nu4seint3grity/video/7032370481013476655
@ChiefNerd
https://www.tiktok.com/@nu4seint3grity/video/7032370481013476655
@ChiefNerd
👍1
Media is too big
VIEW IN TELEGRAM
Joe Rogan & Tristan Harris on What China's Crackdown on Algorithm's Means for the US
https://youtu.be/im4O2sW3FiY
@ChiefNerd
https://youtu.be/im4O2sW3FiY
@ChiefNerd
The polarization of politics according to the latest Pew Survey
Wonder if that FB launch had anything to do with it? 🤔
@ChiefNerd
Wonder if that FB launch had anything to do with it? 🤔
@ChiefNerd
40 Places Where Covid Shots Have Failed To Stop The Spread
“24 countries and 16 states where cases reached new all-time highs after vaccination roll outs”
Follow @KanekoaTheGreat on Substack:
https://kanekoa.substack.com/p/40-places-where-covid-shots-have
@ChiefNerd
“24 countries and 16 states where cases reached new all-time highs after vaccination roll outs”
Follow @KanekoaTheGreat on Substack:
https://kanekoa.substack.com/p/40-places-where-covid-shots-have
@ChiefNerd
This media is not supported in your browser
VIEW IN TELEGRAM
Geert Vanden Bossche: “These vaccines are just going to breed variants but no body is going to listen to you because you go against the mainstream”
Watch the full interview:
https://thehighwire.com/watch/
@ChiefNerd
Watch the full interview:
https://thehighwire.com/watch/
@ChiefNerd
Media is too big
VIEW IN TELEGRAM
Geert Vanden Bossche on the difference between Naturally Acquired Immunity vs Innate Immunity
Watch the full interview:
https://thehighwire.com/watch/
@ChiefNerd
Watch the full interview:
https://thehighwire.com/watch/
@ChiefNerd
Media is too big
VIEW IN TELEGRAM
Geert Vanden Bossche: “So what we are going to do is instead of the population exerting selection pressure on the virus, we are going to allow this virus to exert selection pressure on innate immunity of the host.”
Watch the full interview:
https://thehighwire.com/watch/
@ChiefNerd
Watch the full interview:
https://thehighwire.com/watch/
@ChiefNerd